BG-12 (dimethyl fumarate) is in development as an oral treatment for relapsing–remitting multiple sclerosis, which is commonly treated with parenteral agents (interferon or glatiramer acetate). In ...

, June 28 -- BG Interactive Ltd showcased its next-generation managed cybersecurity services, Security Operations Center (SOC) capabilities and cybersecurity workforce development initiatives at ...

BG-12 (dimethyl fumarate) was shown to have antiinflammatory and cytoprotective properties in preclinical experiments and to result in significant reductions in disease activity on magnetic resonance ...